Literature DB >> 8550782

Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate.

A C Levine1, J P Wang, M Ren, E Eliashvili, D W Russell, A Kirschenbaum.   

Abstract

The activity of the type 2 isozyme of steroid 5 alpha-reductase is crucial for normal development of the external genitalia and prostate in human males. We used immunohistochemistry to localize type 2 isozyme expression in the human male fetal reproductive tract and adult prostate. In fetal tissue, the stroma of the seminal vesicles, corpus cavernosum, corpus spongiosum, dorsal vein complex, scrotal skin, and prostate expressed the enzyme. In addition, the epithelial cells of the fetal urethra and proximal prostatic ducts stained positively. The type 2 isozyme could not be detected in epithelial cells of the fetal prostatic acini, seminal vesicles, prostatic utricle, ejaculatory ducts, epididymides, and Cowper's glands. Adult prostate specimens were derived from transurethral prostatectomies performed for benign prostatic hyperplasia. Enzyme expression in these benign prostatic hyperplasia samples localized to the stroma and epithelial cells of the urethra and proximal ducts. No staining was detected in the acinar (luminal and basal) epithelial cells. Double staining with an antismooth muscle actin antibody localized type 2 isozyme expression to the stromal fibroblast cells of the prostate. Double staining with an androgen receptor antibody localized AR expression to the acinar epithelial cells and stromal fibroblasts. These data indicate that 5 alpha-reductase type 2 is expressed throughout the developing male genitourinary tract and functions as both an autocrine and a paracrine mediator of growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550782     DOI: 10.1210/jcem.81.1.8550782

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis.

Authors:  M Paola Castelli; Alberto Casti; Angelo Casu; Roberto Frau; Marco Bortolato; Saturnino Spiga; Maria Grazia Ennas
Journal:  Psychoneuroendocrinology       Date:  2012-07-08       Impact factor: 4.905

2.  Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.

Authors:  Tyler M Bauman; Priyanka D Sehgal; Karen A Johnson; Thomas Pier; Reginald C Bruskewitz; William A Ricke; Wei Huang
Journal:  Prostate       Date:  2014-04-30       Impact factor: 4.104

Review 3.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 4.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 5.  Development of the human prostate.

Authors:  Gerald R Cunha; Chad M Vezina; Dylan Isaacson; William A Ricke; Barry G Timms; Mei Cao; Omar Franco; Laurence S Baskin
Journal:  Differentiation       Date:  2018-09-04       Impact factor: 3.880

6.  New approaches for estimating risk from exposure to diethylstilbestrol.

Authors:  G R Cunha; J G Forsberg; R Golden; A Haney; T Iguchi; R Newbold; S Swan; W Welshons
Journal:  Environ Health Perspect       Date:  1999-08       Impact factor: 9.031

7.  The analysis of glutamate and glutamine frequencies in human proteins as marker of tissue oxygenation.

Authors:  Annamaria Vernone; Chiara Ricca; Daniela Merlo; Gianpiero Pescarmona; Francesca Silvagno
Journal:  R Soc Open Sci       Date:  2019-04-10       Impact factor: 2.963

8.  Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract.

Authors:  Kimberley Katleba; Erin Legacki; Trish Berger
Journal:  Animals (Basel)       Date:  2022-08-24       Impact factor: 3.231

9.  Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants.

Authors:  Emma Jernberg; Elin Thysell; Erik Bovinder Ylitalo; Stina Rudolfsson; Sead Crnalic; Anders Widmark; Anders Bergh; Pernilla Wikström
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.